What is Scilex Holding Company's acquisitions?

Scilex Holding Company (SCLX) reported acquisitions of $379.25K in Q4 2025.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Scilex Holding Company SCLX Acquisitions

Acquisitions at other companies

PTH

Pelthos Therapeutics Inc.PTHS

$690.25K—

Rigel PharmaceuticalsRIGL

$1.25M0.0%

Opko HealthOPK

$0-100%

Bristol-Myers SquibbBMY

$65M-16.7%

Other financials

Income statement

See full

Revenue$8.6M+72.1%

Gross profit$4.2M+15.1%

Operating income-$32.2M-15.3%

Net income-$45.7M-75.0%

EPS (diluted)-$6.28-178%

Balance sheet

See full

Cash & equivalents$3.4M-42.2%

Total debt$95.4M+130%

Total equity-$249.2M-17.8%

Total assets$293.6M+272%

Cash flow

See full

Operating cash flow-$1.1M-118%

CapEx$33.3K—

Free cash flow$920.8K-63.7%

Valuation

See full

Market cap$54.86M+88.7%

Enterprise value$146.86M+120%

P/S1.6×+1.0×

Profitability

See full

Gross margin59.7%-12.3pp

Operating margin-1,034.4%-1,313pp

Net margin-1,162.4%-1,359pp

FCF margin12.2%—

Returns & leverage

See full

Return on equity170.9%—

Debt / equity0.3×—

Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:CashAcquiredFromAcquisition.

The official record: Scilex Holding Company’s 10-K, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Scilex Holding Company's acquisitions?: Scilex Holding Company (SCLX) reported acquisitions of $379.25K in Q4 2025.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.